Patritumab

Duligotuzumab

Pateclizumab

Immunoglobulin G1, anti-(mucin CanAg) (human-mouse monoclonal C242 heavy chain), disulfide with human-mouse monoclonal C242 light chain, dimer (ACI)

Poly(oxy-1,2-ethanediyl), α-[3-[[[(2R)-2,3-bis(tetradecyloxy)propoxy]carbonyl]amino]propyl]-ω-methoxy- (ACI)

DI 17E6 (ACI)

Mogamulizumab

Gevokizumab

Lebrikizumab

Brodalumab

Solitomab

Swinholide A (ZCI)

L-Phenylalaninamide, N-acetyl-L-tyrosyl-L-threonyl-L-seryl-L-leucyl-L-isoleucyl-L-histidyl-L-seryl-L-leucyl-L-isoleucyl-L-α-glutamyl-L-α-glutamyl-L-seryl-L-glutaminyl-L-asparaginyl-L-glutaminyl-L-glutaminyl-L-α-glutamyl-L-lysyl-L-asparaginyl-L-α-glutamyl-L-glutaminyl-L-α-glutamyl-L-leucyl-L-leucyl-L-α-glutamyl-L-leucyl-L-α-aspartyl-L-lysyl-L-tryptophyl-L-alanyl-L-seryl-L-leucyl-L-tryptophyl-L-asparaginyl-L-tryptophyl-, acetate (9CI, ACI)

Polygalacturonase, Aspergillus niger, endo

Tigatuzumab

Elotuzumab

Suvizumab

Amylase, bacterial (9CI, ACI)

Polygalacturonase (9CI, ACI)

Ficin (8CI, 9CI, ACI)